Health Care·Biotechnology·$5.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.21 | N/A | +73.35% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.21 | N/A | +73.35% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the company's progress despite not providing specific revenue figures. They emphasized their commitment to advancing their pipeline.
We are pleased with our progress in the quarter.
Our focus remains on advancing our pipeline.
Scholar Rock's earnings report shows a significant positive surprise on EPS, indicating better-than-expected loss management. However, the stock fell by 6.63%, likely due to the lack of revenue data and guidance, which may have left investors uncertain about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AST SPACEMOBILE INC Class A
May 16, 2022